Advanced search
Publication Cover
Applied Economics Latest Articles
Submit an article Journal homepage
44
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Measuring the Willingness-to-pay for standardizing medication information: a two-pronged stated preference approach

Bern Caudill Dealya Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD, USACorrespondence[email protected]
,
Carolyn Wolffa Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD, USA
,
Aaron Kearsleyb Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, Washington, D.C, USA
&
Elizabeth Botkinsa Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD, USA
Published online: 03 Dec 2023

References

  • Aker, J., M. Beck, J. I. Papay, T. Cantu, M. Ellis, D. Keravich, and K. Bibeau. 2013. “Consumers Better Understand and Prefer Simplified Written Drug Information: An Evaluation of 2 Novel Formats versus the Current CMI.” Therapeutic Innovation & Regulatory Science 47 (1): 125–132.
  • Carson, R. T., and T. Groves. 2007. “Incentive and Informational Properties of Preference Questions.” Environmental & Resource Economics 37 (1): 181–210. https://doi.org/10.1007/s10640-007-9124-5.
  • Dealy, B. C., A. Kearsley, C. Wolff, E. Botkins, N. Lew, and C. Nardinelli. 2021. “Willingness to Pay to Standardize Patient Medication Information.” Applied Economics 53 (9): 1112–1126. https://doi.org/10.1080/00036846.2020.1826401.
  • Freeman, A. M. 2003. The Measurement of Environmental and Resource Values: Theory and Methods. Washington, D.C., USA: Resources for the Future.
  • Gyrd‐Hansen, D., T. Kjær, and J. S. Nielsen. 2012. “Scope Insensitivity in Contingent Valuation Studies of Health Care Services: Should We Ask Twice?” Health Economics 21 (2): 101–112.
  • Jorgensen, B. S., M. A. Wilson, and T. A. Heberlein. 2001. “Fairness in the Contingent Valuation of Environmental Public Goods: Attitude Toward Paying for Environmental Improvements at Two Levels of Scope.” Ecological Economics 36 (1): 133–148.
  • Kimberlin, C. L., and A. G. Winterstein 2008. Expert and Consumer Evaluation of Consumer Medication Information - 2008. https://ntrl.ntis.gov/NTRL/dashboard/searchResults/titleDetail/PB2009105293.xhtml.
  • Kriström, B. 1997. “Spike models in contingent valuation.” American Journal of Agricultural Economics 79 (3): 1013–1023.
  • Lin, P.-J., M. J. Cangelosi, D. W. Lee, and P. J. Neumann. 2013. “Willingness to Pay for Diagnostic Technologies: A Review of the Contingent Valuation Literature.” Value in Health 16 (5): 797–805.
  • Lo, A. Y., and C. Y. Jim. 2015. “Protest Response and Willingness to Pay for Culturally Significant Urban Trees: Implications for Contingent Valuation Method.” Ecological Economics 114:58–66. https://doi.org/10.1016/j.ecolecon.2015.03.012.
  • Osterberg, L., and T. Blaschke. 2005. “Adherence to Medication.” The New England Journal of Medicine 353 (5): 487–497.
  • Schumock, G. T., E. C. Li, M. D. Wiest, K. J. Suda, J. Stubbings, L. M. Matusiak, and L. C. Vermeulen, L. C. Vermeulen. 2017. “National Trends in Prescription Drug Expenditures and Projections for 2017.” American Journal of Health-System Pharmacy 74 (15): 1158–1173. https://doi.org/10.2146/ajhp170164.
  • Shrank, W. H., and J. Avorn. 2007. “Educating Patients About Their Medications: The Potential and Limitations of Written Drug Information.” Health Affairs 26 (3): 731–740.
  • U.S. Food and Drug Administration. 2019. Medication Adherence: Landscape, Strategies, and Evaluation Methods. https://www.fda.gov/drugs/news-events-human-drugs/medication-adherence-landscape-strategies-and-evaluation-methods-12102019.
  • Yoo, S.-H., and S.-J. Kwak. 2002. “Using a Spike Model to Deal with Zero Response Data from Double Bounded Dichotomous Choice Contingent Valuation Surveys.” Applied Economics Letters 9 (14): 929–932.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.